Ken Griffin LEAP THERAPEUTICS INC Transaction History

Citadel Advisors LLC

  • $550 Billion
  • Q2 2025
Number of Shares
74,931
Previous 30,400 146.48%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
N/A
74,931 New
74,931 $0
Q4 2024

Feb 14, 2025
SELL
N/A
-370,739 Reduced 80.0%
92,709 $0
Q3 2024

Nov 14, 2024
SELL
N/A
-454,658 Reduced 49.52%
463,448 $0
Q2 2024

Aug 14, 2024
BUY
N/A
206,787 Added 29.07%
918,106 $0
Q1 2024

May 15, 2024
BUY
N/A
28,570 Added 4.18%
711,319 $0
Q4 2023

Feb 14, 2024
BUY
N/A
38,530 Added 5.98%
682,749 $0
Q3 2023

Nov 14, 2023
BUY
N/A
559,615 Added 661.45%
644,219 $0
Q2 2023

Aug 14, 2023
BUY
N/A
84,604 New
84,604 $0
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email